The purpose of this in vitro study was to evaluate erosive wear and change in color of high-viscosity glass ionomer cements after pH cycling in two erosive media. There were 3 experimental groups with 22 samples each, (I) EQUIA Forte HT without coat, (II) Fuji IX and (III) Ketac Universal Aplicap. Each group was randomly divided into three subgroups (n = 6–8) further exposed to different environments, (1) distilled water, (2) green tea (pH 3.78) and (3) Aceto balsamico vinegar (pH 3.0). Mass and L* a* b* values were recorded before and after pH cycling. The samples in subgroups 2 and 3 were exposed to the acidic media two times a day for 10 min, over a period of 14 days. The differences among materials and erosive effects of the three media were tested using three-way analyses of variance with post hoc LSD test at the significance level p < 0.05. The effect of pH cycling in Aceto balsamico and green tea was degrading for all three materials. pH cycling in Aceto balsamico caused significantly higher erosive wear than pH cycling in Fuzetea and storage in distilled water, in all materials (p < 0.05). pH cycling in both acidic media and in the control group resulted in a significant change in L* a* and b* (p < 0.05). The L* value decreased significantly and the a* and b* values increased significantly (p < 0.05).
Every year, with the increasing number of dental implants placed, there is an increase in the incidence of peri-implantitis. The treatment of peri-implantitis is very complex and among other things includes mechanical and chemical decontamination of the implant surfaces, which is very challenging and often not predictable due to the surface properties of the implants. Photodynamic therapy recently has emerged as a potential treatment alternative or adjuvant treatment to peri-implantitis. Its potential to decontaminate implant surfaces without damaging the surface and the implants surrounding tissues has generated much interest in the scientific community. The possibilities of photodynamic therapy in treatment of peri-implantitis are opening new challenges in establishing optimal conditions for the clinical application of aPDT. Due to its non-invasiveness and ease of use this method can be effective when applied alone or as an adjunct therapy to conventional methods for treating peri-implantitis.
The term “periapical lesion” refers to a pathological change in the tissues surrounding the apex of a tooth root, defined by its anatomical location rather than a distinct disease entity. Periapical lesions may be of endodontic origin, most commonly resulting from microbial infection of the root canal system following pulp necrosis due to caries, trauma, or other insults, or of non-endodontic origin, such as developmental cysts, benign and malignant odontogenic and non-odontogenic tumors, and fibro-osseous lesions. Accurate diagnosis requires a systematic approach combining patient history, clinical examination, pulp vitality testing, and radiographic assessment; histopathological evaluation is indicated when clinical and radiographic findings are inconsistent or suspicious. The pathophysiology of these lesions involves dynamic interactions between root canal microorganisms and the host immune-inflammatory response. The primary management for endodontic periapical lesions is root canal treatment, which aims to reduce or eliminate root canal microorganisms through mechanical debridement and chemical disinfection. Persistent or extensive endodontic lesions and non-endodontic lesions may require surgical intervention. Molecular and inflammatory biomarkers have been investigated as adjunctive tools for assessing disease activity and prognosis; however, these remain largely investigational and are not yet part of routine clinical practice. Future developments in artificial intelligence, advanced imaging, molecular diagnostics, and personalized therapies may enhance the diagnosis and management of periapical lesions, although further clinical validation is required.
Magnesium-based membranes are promising biomaterials for guided bone regeneration due to their unique properties of mechanical strength, biocompatibility, and controlled biodegradation. This scoping review aimed to map and synthesize the available evidence regarding the use of magnesium-based membranes and fixation screws in alveolar ridge regeneration and guided bone regeneration procedures. Relevant studies were identified through a literature search conducted from November 2025 to May 2026, using several databases following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. Thirty-nine studies met the inclusion criteria, including in vitro studies, preclinical animal studies, clinical case reports and case series, and narrative or systematic reviews. In vitro studies demonstrated cytocompatibility and fibroblast adhesion, while moderate magnesium ion concentrations increased markers of osteogenic differentiation. Preclinical animal studies reported controlled degradation, biocompatible tissue responses, maintenance of barrier function during early healing, and findings suggesting potential osteogenic stimulation. Clinical evidence, limited to case reports and small case series, described the use of magnesium membranes in horizontal and vertical ridge augmentation, sinus lift procedures, immediate dentoalveolar regeneration, periodontal defects, and cystic lesions, with generally uneventful healing outcomes and preserved bone volume. Reported complications were mainly minor and included transient soft tissue reactions, membrane exposure, and localized gas cavity formation. However, the available evidence remains limited to low-level studies without controlled clinical trials. Current findings are insufficient to establish clinical efficacy or superiority over conventional membranes, highlighting the need for larger prospective controlled studies. The review’s findings could help researchers advance the understanding of bone regeneration and help develop new strategies to improve and further investigate bone regeneration.
Osteonecrosis as term represents the death of bone tissue in the body and causes of necrosis can be different. Medication-related osteonecrosis of the jaws (MRONJ) is nowadays known as an inability of the alveolar bone to respond to a local trauma and it can result in severe local and systemic complications. In the etiology of medication-related osteonecrosis there are antiangiogenic and antiresorptive agents which have great effect on alveolar bone, producing an imbalance between resorption (osteoclastic activity) and deposition (osteoblastic activity). The exact mechanisms of development are not todays completely resolved. It is thought that it is a result from combination of medication interactions, microbiological contamination of the area and local tissue trauma. Typical signs and symptoms are painful mucosal lesions, swelling, exposed necrotic bone in the jaws, discomfort and dysesthesias. There is currently no gold standard or clearly defined treatment protocol for the disease itself. Process of treatment is demanding and main goal is to eliminate pain, control infection of soft and hard tissue and minimize progression of osteonecrosis. Besides the conventional surgical treatment, photodynamic therapy can be a viable supportive tool of initial and advanced stages of osteonecrosis and may contribute to improvements of patient′s quality of life.